Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials
Author:
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry, medical,Clinical Biochemistry,Molecular Medicine
Link
https://link.springer.com/content/pdf/10.1186/2050-7771-1-1.pdf
Reference5 articles.
1. Lamba G, Ambrale S, Lee B, Gupta R, Rafiyath SM, Liu D: Recent advances and novel agents for gastrointestinal stromal tumor (GIST). J Hematol Oncol 2012, 5: 21. 10.1186/1756-8722-5-21
2. Lamba G, Gupta R, Lee B, Ambrale S, Liu D: Current management and prognostic features for gastrointestinal stromal tumor (GIST). Experimental Hematology & Oncology 2012,1(1):14. 10.1186/2162-3619-1-14
3. Lee B, Mukhi N, Liu D: Current management and novel agents for malignant melanoma. J Hematol Oncol 2012, 5: 3. 10.1186/1756-8722-5-3
4. Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, et al.: Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med 2010,362(24):2251–2259. 10.1056/NEJMoa0912614
5. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, et al.: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011,364(26):2507–2516. 10.1056/NEJMoa1103782
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Novel biomarkers for detection of nephrotoxicity;Journal of Renal Injury Prevention;2024-05-26
2. Serine/threonine-protein kinase B-Raf inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024
3. Inhibitory effects of aloin on lipopolysaccharide-induced severe inflammatory responses;Journal of Asian Natural Products Research;2022-01-13
4. Biomarker-Based Drug Discovery with Reverse Translational Approach;Biomedical Translational Research;2022
5. Development of Novel Cancer Biomarkers for Diagnosis and Prognosis;Cancer Biomarkers in Diagnosis and Therapeutics;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3